As of May 2024 Bristol-Myers Squibb has a market cap of $89.17 Billion. This makes Bristol-Myers Squibb the world's 172th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $89.17 B | -14.59% |
2023 | $104.40 B | -31.75% |
2022 | $152.97 B | 10.54% |
2021 | $138.39 B | -1.27% |
2020 | $140.17 B | -1.99% |
2019 | $143.01 B | 69.42% |
2018 | $84.41 B | -15.83% |
2017 | $100.29 B | 2.69% |
2016 | $97.66 B | -14.52% |
2015 | $114.26 B | 17.1% |
2014 | $97.57 B | 11.88% |
2013 | $87.21 B | 64.19% |
2012 | $53.12 B | -11.04% |
2011 | $59.71 B | 32.73% |
2010 | $44.98 B | 4.26% |
2009 | $43.15 B | -6.24% |
2008 | $46.02 B | -12.08% |
2007 | $52.35 B | 1.38% |
2006 | $51.63 B | 14.83% |
2005 | $44.97 B | -9.84% |
2004 | $49.88 B | -10.1% |
2003 | $55.48 B | 22.68% |
2002 | $45.22 B | -54.81% |
2001 | $100.07 B |
On May 3rd, 2024 the market cap of Bristol-Myers Squibb was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $359.24 B | 302.87% | ๐บ๐ธ USA |
Novartis NVS | $198.47 B | 122.57% | ๐จ๐ญ Switzerland |
Pfizer PFE | $157.47 B | 76.60% | ๐บ๐ธ USA |
AbbVie ABBV | $290.01 B | 225.23% | ๐บ๐ธ USA |
Eli Lilly LLY | $698.51 B | 683.34% | ๐บ๐ธ USA |
Amgen AMGN | $166.96 B | 87.24% | ๐บ๐ธ USA |
Sanofi SNY | $123.36 B | 38.34% | ๐ซ๐ท France |
Biogen BIIB | $31.66 B | -64.49% | ๐บ๐ธ USA |
Merck MRK | $322.98 B | 262.21% | ๐บ๐ธ USA |
AstraZeneca AZN | $237.33 B | 166.16% | ๐ฌ๐ง UK |